seed
Stage
1
Investors
About
PhosPrint develops laser bioprinting systems for precise delivery of cells and bio-inks in vivo for regenerative medicine and biosensor applications. Its lead program focuses on in‑vivo urinary bladder repair, having completed preclinical studies and advancing toward clinical trials.
Explore PhosPrint's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.